Biopharma regulators across Asia are undergoing major restructuring as China, India and other countries seek to protect their share of drug exports in the face of stiffer manufacturing compliance demands in the West and pressure to adopt international standards. Read More
SHANGHAI – For Shenogen, one of the growing number of innovative drug development companies in China, industry accolades are a welcome acknowledgement of years of hard work. Read More
HONG KONG – Authorities in China are working to plug a regulatory hole related to post-market studies for new chemical entities (NCE) and biological drugs. Read More
• Prana Biotechnology Ltd., of Melbourne, Australia, said an article in the peer-reviewed journal Aging Cell showed favorable effects of PBT2 on neurogenesis and in reversing the memory and learning losses associated with the aging process, in normal (i.e., nontransgenic) old mice. Read More
